ZA200500203B - Novel compounds, pharmaceutical compositions containing same, and methods of use for same - Google Patents
Novel compounds, pharmaceutical compositions containing same, and methods of use for sameInfo
- Publication number
- ZA200500203B ZA200500203B ZA200500203A ZA200500203A ZA200500203B ZA 200500203 B ZA200500203 B ZA 200500203B ZA 200500203 A ZA200500203 A ZA 200500203A ZA 200500203 A ZA200500203 A ZA 200500203A ZA 200500203 B ZA200500203 B ZA 200500203B
- Authority
- ZA
- South Africa
- Prior art keywords
- same
- methods
- pharmaceutical compositions
- compositions containing
- novel compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39280902P | 2002-07-01 | 2002-07-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200500203B true ZA200500203B (en) | 2009-09-30 |
Family
ID=30115535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200500203A ZA200500203B (en) | 2002-07-01 | 2003-07-01 | Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20060241177A1 (zh) |
| EP (1) | EP1534263A4 (zh) |
| JP (1) | JP2005533107A (zh) |
| KR (1) | KR20050072670A (zh) |
| CN (2) | CN101633650A (zh) |
| AU (1) | AU2003248810B2 (zh) |
| BR (1) | BRPI0312413A2 (zh) |
| CA (1) | CA2491183A1 (zh) |
| EA (1) | EA010484B1 (zh) |
| HK (1) | HK1086485A1 (zh) |
| IL (1) | IL166054A0 (zh) |
| MX (1) | MXPA05000152A (zh) |
| SG (1) | SG170620A1 (zh) |
| WO (1) | WO2004006835A2 (zh) |
| ZA (1) | ZA200500203B (zh) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9018737D0 (en) * | 1990-08-28 | 1990-10-10 | Goodfellow John W | Phosphetic patellar components |
| MXPA04007556A (es) | 2002-02-08 | 2005-12-05 | Univ Johns Hopkins Med | Estimulacion de cpt-1 como medio para reducir peso. |
| ZA200500166B (en) * | 2002-07-09 | 2007-08-29 | Fasgen Llc | Methods of treating microbial infections in humans and animals |
| CN101007796A (zh) * | 2006-01-27 | 2007-08-01 | 北京摩力克科技有限公司 | 新型五元杂环化合物及其制备方法和医疗用途 |
| CN101190904A (zh) * | 2006-11-23 | 2008-06-04 | 中国人民解放军军事医学科学院毒物药物研究所 | 脂肪酸合成酶抑制剂及其制药用途 |
| CN101820757A (zh) | 2007-06-01 | 2010-09-01 | 普林斯顿大学托管委员会 | 通过调节宿主细胞代谢途径治疗病毒感染 |
| US8729239B2 (en) | 2009-04-09 | 2014-05-20 | Nuclea Biotechnologies, Inc. | Antibodies against fatty acid synthase |
| FR2957078B1 (fr) * | 2010-03-05 | 2012-05-04 | Centre Nat Rech Scient | Acides paraconiques comme activateurs de pigmentation |
| EP3159331A1 (en) | 2010-05-05 | 2017-04-26 | Infinity Pharmaceuticals, Inc. | Tetrazolones as inhibitors of fatty acid synthase |
| WO2011140296A1 (en) | 2010-05-05 | 2011-11-10 | Infinity Pharmaceuticals | Triazoles as inhibitors of fatty acid synthase |
| WO2014039769A1 (en) * | 2012-09-07 | 2014-03-13 | Janssen Pharmaceutica Nv | Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer |
| CN103145662B (zh) * | 2013-02-18 | 2014-07-16 | 深圳万和制药有限公司 | N-取代的氨基丁内酯衍生物及其用途 |
| CN103864731B (zh) * | 2014-02-19 | 2016-01-20 | 成都中医药大学 | 含季碳手性中心的呋喃内酯环类化合物的合成方法 |
| CN104530018B (zh) * | 2014-12-12 | 2017-04-12 | 郑州大学 | 含α‑亚甲基‑γ‑丁内酯结构的吲哚类化合物、制备方法及其应用 |
| CA2975877A1 (en) * | 2015-02-05 | 2016-08-11 | Anthony Adrian Shaw | Synthetic process for preparing 2-((2-ethoxy-2-oxoethyl)(methyl)amino)-2-oxoethyl 5-tetradecyloxy)furan-2-carboxylate |
| KR102038971B1 (ko) * | 2018-03-12 | 2019-11-26 | 주식회사 엔지켐생명과학 | 디아실글리세롤락톤 화합물, 그 제조방법 및 이를 유효성분으로 함유하는 면역증진제 |
| KR20220159831A (ko) | 2021-05-26 | 2022-12-05 | 울산과학기술원 | 미토콘드리아 표적화 뉴클레오펩티드 및 이를 포함하는 암의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3496187A (en) * | 1967-03-20 | 1970-02-17 | American Home Prod | N-(heterocyclyl)aconamides |
| US3472878A (en) * | 1969-01-27 | 1969-10-14 | American Home Prod | N-(hydroxyaryl)aconamides |
| US4753871A (en) * | 1986-12-12 | 1988-06-28 | Eastman Kodak Company | Cyan dye-forming couplers and photographic materials containing same |
| JPS63169848A (ja) * | 1987-01-07 | 1988-07-13 | Nec Corp | デジタルデ−タ通信におけるデ−タ端末収容方式 |
| JP2524760B2 (ja) * | 1987-07-10 | 1996-08-14 | テイカ株式会社 | 新規抗生物質 |
| JPH04199148A (ja) * | 1990-11-29 | 1992-07-20 | Konica Corp | ハロゲン化銀写真感光材料 |
| JPH05246822A (ja) * | 1992-03-07 | 1993-09-24 | Nippon Paint Co Ltd | 抗菌剤 |
| JPH07112931A (ja) * | 1993-08-27 | 1995-05-02 | Nippon Paint Co Ltd | エプスタイン−バーウイルス活性化抑制剤 |
| AU7668596A (en) * | 1995-11-17 | 1997-06-11 | Johns Hopkins University, The | Inhibition of fatty acid synthase as a means to reduce adipocyte mass |
| KR20090130151A (ko) * | 1999-11-12 | 2009-12-17 | 더 존스 홉킨스 유니버시티 | 세포내 말로닐 ＣｏＡ의 수준을 증가시킴에 의한 암의 치료 방법 |
| WO2001060174A2 (en) * | 2000-02-16 | 2001-08-23 | The Johns Hopkins University School Of Medicine | Weight loss induced by reduction in neuropeptide y level |
-
2003
- 2003-07-01 CN CN200910126506A patent/CN101633650A/zh active Pending
- 2003-07-01 EP EP03764343A patent/EP1534263A4/en not_active Withdrawn
- 2003-07-01 US US10/519,804 patent/US20060241177A1/en not_active Abandoned
- 2003-07-01 CN CNB038183692A patent/CN100482219C/zh not_active Expired - Fee Related
- 2003-07-01 KR KR1020047021601A patent/KR20050072670A/ko not_active Application Discontinuation
- 2003-07-01 MX MXPA05000152A patent/MXPA05000152A/es not_active Application Discontinuation
- 2003-07-01 WO PCT/US2003/020960 patent/WO2004006835A2/en active Application Filing
- 2003-07-01 ZA ZA200500203A patent/ZA200500203B/xx unknown
- 2003-07-01 IL IL16605403A patent/IL166054A0/xx unknown
- 2003-07-01 SG SG200806631-8A patent/SG170620A1/en unknown
- 2003-07-01 CA CA002491183A patent/CA2491183A1/en not_active Abandoned
- 2003-07-01 EA EA200500122A patent/EA010484B1/ru not_active IP Right Cessation
- 2003-07-01 BR BRPI0312413A patent/BRPI0312413A2/pt not_active IP Right Cessation
- 2003-07-01 JP JP2004521521A patent/JP2005533107A/ja active Pending
- 2003-07-01 AU AU2003248810A patent/AU2003248810B2/en not_active Ceased
-
2006
- 2006-06-07 HK HK06106502.2A patent/HK1086485A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EA010484B1 (ru) | 2008-10-30 |
| IL166054A0 (en) | 2006-01-15 |
| EP1534263A2 (en) | 2005-06-01 |
| KR20050072670A (ko) | 2005-07-12 |
| CN100482219C (zh) | 2009-04-29 |
| JP2005533107A (ja) | 2005-11-04 |
| CN1705478A (zh) | 2005-12-07 |
| EA200500122A1 (ru) | 2005-12-29 |
| SG170620A1 (en) | 2011-05-30 |
| BRPI0312413A2 (pt) | 2016-08-02 |
| CA2491183A1 (en) | 2004-01-22 |
| WO2004006835A3 (en) | 2004-07-22 |
| HK1086485A1 (en) | 2006-09-22 |
| MXPA05000152A (es) | 2005-10-24 |
| AU2003248810B2 (en) | 2009-08-20 |
| US20060241177A1 (en) | 2006-10-26 |
| CN101633650A (zh) | 2010-01-27 |
| EP1534263A4 (en) | 2006-10-11 |
| AU2003248810A1 (en) | 2004-02-02 |
| WO2004006835A2 (en) | 2004-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL190218A0 (en) | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | |
| HK1086485A1 (en) | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | |
| AU2002363236A1 (en) | Compounds, pharmaceutical compositions and methods of use therefor | |
| HK1093975A1 (en) | Ppar-activating compound and pharmaceutical composition containing same | |
| IL173930A0 (en) | Pharmaceutical compositions containing forms of r-baclofen | |
| IL164798A0 (en) | Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| GB2394894B (en) | New use for pharmaceutical composition | |
| IL164455A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL164987A0 (en) | Proline derivatives and pharmaceutical compositions containing | |
| EP1626717A4 (en) | BENZIMIDAZOLE, COMPOSITIONS AND METHOD OF ADMINISTRATION CONTAINING SUCH COMPOUNDS | |
| AU2003239302A1 (en) | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them | |
| HUP0400194A3 (en) | Imidazolidindion derivatives as metalloproteinase inhibitors, their use and pharmaceutical compositions containing them | |
| HUP0401333A3 (en) | Spiropyrazole compounds and pharmaceutical compositions containing them | |
| EP1569915A4 (en) | SPIROCYCLIC UREAS, COMPOSITIONS CONTAINING SAME, AND METHODS OF USE | |
| IL158898A0 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND DERIVATIVES THEREOF | |
| HUP0400193A3 (en) | Imidazolindion derivatives as metalloproteinase inhibitors, their use and pharmaceutical compositions containing them | |
| IL166621A0 (en) | Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same | |
| HUP0401747A3 (en) | Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds | |
| IL179530A0 (en) | Novel compounds, pharmaceutical compositions containing same and methods of use for same | |
| AU2003269421A8 (en) | Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use | |
| IL176077A0 (en) | 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them | |
| PL367128A1 (en) | Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors | |
| AU2003231920A8 (en) | Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them | |
| IL153098A0 (en) | Pharmaceutical compositions containing modafinil | |
| ZA200601232B (en) | 3-Aryl-4-hydroxyfuranone compounds and pharmaceutical and veterinary compositions containing them |